Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside
Sarmistha Mukherjee, … , Karthikeyani Chellappa, Joseph A. Baur
Sarmistha Mukherjee, … , Karthikeyani Chellappa, Joseph A. Baur
Published March 9, 2021
Citation Information: JCI Insight. 2021;6(7):e147193. https://doi.org/10.1172/jci.insight.147193.
View: Text | PDF
Research Article Hepatology Metabolism

SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside

  • Text
  • PDF
Abstract

Liver regeneration is critical to survival after traumatic injuries, exposure to hepatotoxins, or surgical interventions, yet the underlying signaling and metabolic pathways remain unclear. In this study, we show that hepatocyte-specific loss of the mitochondrial deacetylase SIRT3 drastically impairs regeneration and worsens mitochondrial function after partial hepatectomy. Sirtuins, including SIRT3, require NAD as a cosubstrate. We previously showed that the NAD precursor nicotinamide riboside (NR) promotes liver regeneration, but whether this involves sirtuins has not been tested. Here, we show that despite their NAD dependence and critical roles in regeneration, neither SIRT3 nor its nuclear counterpart SIRT1 is required for NR to enhance liver regeneration. NR improves mitochondrial respiration in regenerating WT or mutant livers and rapidly increases oxygen consumption and glucose output in cultured hepatocytes. Our data support a direct enhancement of mitochondrial redox metabolism as the mechanism mediating improved liver regeneration after NAD supplementation and exclude signaling via SIRT1 and SIRT3. Therefore, we provide the first evidence to our knowledge for an essential role for a mitochondrial sirtuin during liver regeneration and insight into the beneficial effects of NR.

Authors

Sarmistha Mukherjee, James Mo, Lauren M. Paolella, Caroline E. Perry, Jade Toth, Mindy M. Hugo, Qingwei Chu, Qiang Tong, Karthikeyani Chellappa, Joseph A. Baur

×

Figure 1

SIRT1 is not required for nicotinamide riboside to enhance liver regeneration.

Options: View larger image (or click on image) Download as PowerPoint
SIRT1 is not required for nicotinamide riboside to enhance liver regener...
Sirt1 liver-specific-KO mice (denoted as Sirt1–/–) and floxed littermates lacking Albumin Cre (denoted as Sirt1+/+) were subjected to partial hepatectomy (PHx) after 2 weeks of nicotinamide riboside (NR) supplementation. (A) Photographs of regenerating livers 36 hours after PHx. (B) Liver-to-body weight ratios at 24 hours (n = 4–7 per group) and 36 hours (n = 10–14 per group) after PHx. (C) Immunofluorescence showing proliferating hepatocytes (red) detected by EdU and counterstained with DAPI (blue). (D) Quantification of EdU-positive hepatocytes (n = 5 per group). (E) Hepatic lipid content as determined by triglyceride assay. (F) Representative liver sections stained with H&E. (G and H) Hepatic NAD and ATP content in PHx livers prior to and after 36 hours from control or NR-treated mice. High power field, 40× objective, 400× magnification for images in C and F. Data are shown as the mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; 1-way ANOVA followed by Tukey’s post hoc test (B, D, E, G, and H).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts